Troy M. Martin

Infectious Disease

747 Broadway
Seattle, WA 98122

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Development of adjuvanted HIV vaccines tailored for early life: immunologic rationale, clinical experience, and future directions.

Development of adjuvanted HIV vaccines tailored for early life: immunologic rationale, clinical experience, and future directions.

Journal: Current opinion in HIV and AIDS

Published: September 02, 2026

Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trials.

Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trials.

Journal: Clinical trials (London, England)

Published: July 05, 2025

Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns.

Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns.

Journal: medRxiv : the preprint server for health sciences

Published: November 01, 2024

Integration of Preclinical and Clinical Vaccine Safety and Immunogenicity Testing for Development of a Pediatric HIV Vaccine to Achieve Protective HIV Immunity Prior to Adolescence.

Integration of Preclinical and Clinical Vaccine Safety and Immunogenicity Testing for Development of a Pediatric HIV Vaccine to Achieve Protective HIV Immunity Prior to Adolescence.

Journal: Current HIV research

Published: October 24, 2024

Characterization of Early Viral Populations in Infants Acquiring HIV Through Perinatal and Breastmilk Transmission: A Review of what is Currently Known and the Gaps that Need to be Addressed to Guide Passive HIV Immunization of Breastfeeding Infants.

Characterization of Early Viral Populations in Infants Acquiring HIV Through Perinatal and Breastmilk Transmission: A Review of what is Currently Known and the Gaps that Need to be Addressed to Guide Passive HIV Immunization of Breastfeeding Infants.

Journal: Current HIV research

Published: October 16, 2024

Characterization of Early Viral Populations in Infants Acquiring HIV Through Perinatal and Breastmilk Transmission: A Review of what is Currently Known and the Gaps that Need to be Addressed to Guide Passive HIV Immunization of Breastfeeding Infants.

Characterization of Early Viral Populations in Infants Acquiring HIV Through Perinatal and Breastmilk Transmission: A Review of what is Currently Known and the Gaps that Need to be Addressed to Guide Passive HIV Immunization of Breastfeeding Infants.

Journal: Current HIV research

Published: October 16, 2024

Safety and implementation of phase I randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns.

Safety and implementation of phase I randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns.

Journal: The Journal of clinical investigation

Published: September 10, 2024

ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost.

ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost.

Journal: PLOS global public health

Published: September 05, 2024

Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania.

Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania.

Journal: Malaria journal

Published: December 09, 2023

Discovery medicine - the HVTN's iterative approach to developing an HIV-1 broadly neutralizing vaccine.

Discovery medicine - the HVTN's iterative approach to developing an HIV-1 broadly neutralizing vaccine.

Journal: Current opinion in HIV and AIDS

Published: September 15, 2023

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.

Journal: Malaria journal

Published: January 14, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026